1.Risk Factors for Mortality of Bloodstream Infections in Patients with Hematologic Diseases
Guoyang ZHANG ; Pengfeng YANG ; Xiuju WANG ; Yiqing LI ; Jie XIAO ; Hongyun LIU ; Jianxing CHANG ; Liping MA
Journal of Sun Yat-sen University(Medical Sciences) 2017;38(4):622-627
[Objective] To explore the risk factors for mortality of bloodstream infections in the patients with hematologic diseases,so as to provide evidence for reasonable and effective application of treatments.[Methods] The clinical data of 242 cases of bloodstream infections who were hospitalized from Jan 2012 to Jun 2016 were analyzed retrospectively,then the analysis was performed for risk factors.The statistical analysis was processed by SPSS 19.0.[Results] A total of 266 strains of pathogens were isolated,including 99 strains of gram-positive bacteria,accounting for 37.2%,and 164 strains of gram-negative bacteria,accounting for 61.7%.Multivariate analysis showed that the significant independent risk factors for mortality were active states of hematologic diseases (P =0.007,OR =5.622,95% CI 1.586 ~ 19.924),presentation with septic shock(P =0.007,OR =4.978,95% CI 1.560 ~15.884),cardiac insufficiency (P =0.001,OR =11.878,95% CI 2.760 ~ 51.120),level of albumin less than 35 g/L (P =0.036,OR =3.468,95% CI 1.087 ~ 11.066),polymicrobial infection (P =0.010,OR =6.024,95% CI 1.540 ~ 23.563),and Staphylococcus haemolyticus (P =0.001,OR =19.308,95% CI 3.392 ~ 109.888)/Enterococcus (P =0.002,OR =15.266,95% CI 2.817 ~82.728) infection.The survival curves show that the inappropriate initial antimicrobial therapy group or presentation with any one of the independent risk factors had a lower probability of survival than the control group.[Conclusions] Bloodstream infections in patients may cause high mortality rate,so it is necessary that we use antibiotic reasonably and spare no effort to reduce the mortality rate by appropriate application of antimicrobial therapy and effective intervention of the risk factors.
2.Mitochondrion-processed TERC regulates senescence without affecting telomerase activities.
Qian ZHENG ; Peipei LIU ; Ge GAO ; Jiapei YUAN ; Pengfeng WANG ; Jinliang HUANG ; Leiming XIE ; Xinping LU ; Fan DI ; Tanjun TONG ; Jun CHEN ; Zhi LU ; Jisong GUAN ; Geng WANG
Protein & Cell 2019;10(9):631-648
Mitochondrial dysfunctions play major roles in ageing. How mitochondrial stresses invoke downstream responses and how specificity of the signaling is achieved, however, remains unclear. We have previously discovered that the RNA component of Telomerase TERC is imported into mitochondria, processed to a shorter form TERC-53, and then exported back to the cytosol. Cytosolic TERC-53 levels respond to mitochondrial functions, but have no direct effect on these functions, suggesting that cytosolic TERC-53 functions downstream of mitochondria as a signal of mitochondrial functions. Here, we show that cytosolic TERC-53 plays a regulatory role on cellular senescence and is involved in cognition decline in 10 months old mice, independent of its telomerase function. Manipulation of cytosolic TERC-53 levels affects cellular senescence and cognition decline in 10 months old mouse hippocampi without affecting telomerase activity, and most importantly, affects cellular senescence in terc cells. These findings uncover a senescence-related regulatory pathway with a non-coding RNA as the signal in mammals.